Boston Scientific (BSX) gains after topping Q1 estimates

Go back to Boston Scientific (BSX) gains after topping Q1 estimates

Boston Scientific (BSX) Tops Q1 EPS by 4c; offers guidance

April 26, 2023 6:32 AM EDT

Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.47, $0.04 better than the analyst estimate of $0.43. Revenue for the quarter came in at $3.39 billion versus the consensus estimate of $3.16 billion.

GUIDANCE:

Boston Scientific sees Q2 2023 EPS of $0.48-$0.50, versus the consensus of... More